J. Lejeune, M. Gautier, and R. Turpin, Study of somatic chromosomes from 9 mongoloid children, C R Hebd Seances Acad Sci, vol.248, pp.1721-1722, 1959.

C. Epstein, C. Scriver, A. Beaudet, W. Sly, and D. Valle, Down syndrome (Trisomy 21) The metabolic and molecular bases of inherited disease, pp.749-794, 1995.

S. Antonarakis, R. Lyle, E. Dermitzakis, A. Reymond, and S. Deutsch, Chromosome 21 and down syndrome: from genomics to pathophysiology, Nature Reviews Genetics, vol.46, issue.10, pp.725-738, 2004.
DOI : 10.1002/dvdy.20079

L. Dauphinot, R. Lyle, I. Rivals, M. Dang, and R. Moldrich, The cerebellar transcriptome during postnatal development of the Ts1Cje mouse, a segmental trisomy model for Down syndrome, Human Molecular Genetics, vol.14, issue.3, pp.373-384, 2005.
DOI : 10.1093/hmg/ddi033

R. Chapman and L. Hesketh, Behavioral phenotype of individuals with Down syndrome, Mental Retardation and Developmental Disabilities Research Reviews, vol.100, issue.2, pp.84-95, 2000.
DOI : 10.1002/1098-2779(2000)6:2<84::AID-MRDD2>3.0.CO;2-P

R. Chapman and L. Hesketh, Language, cognition, and short-term memory in individuals with Down syndrome, Down Syndrome Research and Practice, vol.7, issue.1, pp.1-7, 2001.
DOI : 10.3104/reviews.108

M. Pogribna, S. Melnyk, I. Pogribny, A. Chango, and P. Yi, Homocysteine Metabolism in Children with Down Syndrome: In Vitro Modulation, The American Journal of Human Genetics, vol.69, issue.1, pp.88-95, 2001.
DOI : 10.1086/321262

M. Botez, T. Botez, J. Leveille, P. Bielmann, and M. Cadotte, Neuropsychological correlates of folic acid deficiency: facts and hypotheses Folic acid in neurology, psychiatry end internal medicine, pp.435-461, 1979.

C. Enk, K. Hougaard, and E. Hippe, Reversible Dementia and Neuropathy Associated with Folate Deficiency 16 Years After Partial Gastrectomy, Scandinavian Journal of Haematology, vol.50, issue.1, pp.63-66, 1980.
DOI : 10.1111/j.1600-0609.1981.tb01366.x

P. Quadri, C. Fragiacomo, R. Pezzati, E. Zanda, and G. Forloni, Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia, Am J Clin Nutr, vol.80, pp.114-122, 2004.

P. Quadri, C. Fragiacomo, R. Pezzati, E. Zanda, and M. Tettamanti, Homocysteine and B vitamins in mild cognitive impairment and dementia, Clinical Chemical Laboratory Medicine, vol.43, issue.10, pp.1096-1100, 2005.
DOI : 10.1515/CCLM.2005.191

S. Blaise, E. Nedelec, H. Schroeder, J. Alberto, and C. Bossenmeyer-pourie, Gestational Vitamin B Deficiency Leads to Homocysteine-Associated Brain Apoptosis and Alters Neurobehavioral Development in Rats, The American Journal of Pathology, vol.170, issue.2, pp.667-679, 2007.
DOI : 10.2353/ajpath.2007.060339
URL : https://hal.archives-ouvertes.fr/hal-00466548

J. Durga, M. Van-boxtel, E. Schouten, M. Bots, and F. Kok, Folate and the methylenetetrahydrofolate reductase 677C???T mutation correlate with cognitive performance, Neurobiology of Aging, vol.27, issue.2, pp.334-343, 2006.
DOI : 10.1016/j.neurobiolaging.2005.01.003

M. Ramos, L. Allen, M. Haan, R. Green, and J. Miller, Plasma folate concentrations are associated with depressive symptoms in elderly Latina women despite folic acid fortification, Am J Clin Nutr, vol.80, pp.1024-1028, 2004.

M. Ramos, L. Allen, D. Mungas, W. Jagust, and M. Haan, Low folate status is associated with impaired cognitive function and dementia in the Sacramento Area Latino Study on Aging, Am J Clin Nutr, vol.82, pp.1346-1352, 2005.

M. Malouf, E. Grimley, and S. Areosa, Folic acid with or without vitamin B12 for cognition and dementia, Cochrane Database Syst Rev, vol.77, issue.9, p.4514, 2003.
DOI : 10.1002/14651858.CD004514

M. Botez, M. Cadotte, R. Beaulieu, L. Pichette, and C. Pison, Neurologic disorders responsive to folic acid therapy, Can Med Assoc J, vol.115, pp.217-223, 1976.

J. Durga, M. Van-boxtel, E. Schouten, F. Kok, and J. Jolles, Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial, The Lancet, vol.369, issue.9557, pp.208-216, 2007.
DOI : 10.1016/S0140-6736(07)60109-3

T. Yang-feng, Y. Ma, R. Liang, P. Prasad, and F. Leibach, Assignment of the Human Folate Transporter Gene to Chromosome 21q22.3 by Somatic Cell Hybrid Analysis and in Situ Hybridization, Biochemical and Biophysical Research Communications, vol.210, issue.3, pp.874-879, 1995.
DOI : 10.1006/bbrc.1995.1739

N. Roizen and D. Patterson, Down's syndrome, The Lancet, vol.361, issue.9365, pp.1281-1289, 2003.
DOI : 10.1016/S0140-6736(03)12987-X

J. Lejeune, M. Rethore, M. De-blois, M. Peeters, and J. Naffah, Amino acids and trisomy 21, Ann Genet, vol.35, pp.8-13, 1992.

J. Gueant, G. Anello, P. Bosco, R. Gueant-rodriguez, and A. Romano, Homocysteine and related genetic polymorphisms in Down's syndrome IQ, Journal of Neurology, Neurosurgery & Psychiatry, vol.76, issue.5, pp.706-709, 2005.
DOI : 10.1136/jnnp.2004.039875

B. Chadefaux, I. Ceballos, M. Hamet, M. Coude, and M. Poissonnier, IS ABSENCE OF ATHEROMA IN DOWN SYNDROME DUE TO DECREASED HOMOCYSTEINE LEVELS?, The Lancet, vol.332, issue.8613, p.741, 1988.
DOI : 10.1016/S0140-6736(88)90211-5

O. David, G. Fiorucci, M. Tosi, F. Altare, and A. Valori, Hematological Studies in Children with Down Syndrome, Pediatric Hematology and Oncology, vol.3, issue.3, pp.271-275, 1996.
DOI : 10.1016/S0022-3476(87)80131-2

M. Peeters, A. Poon, A. Zipursky, and J. Lejeune, TOXICITY OF LEUKAEMIA THERAPY IN CHILDREN WITH DOWN SYNDROME, The Lancet, vol.328, issue.8518, p.1279, 1986.
DOI : 10.1016/S0140-6736(86)92704-2

J. Taub and Y. Ge, Down syndrome, drug metabolism and chromosome 21, Pediatric Blood & Cancer, vol.58, issue.1, pp.33-39, 2005.
DOI : 10.1002/pbc.20092

M. Peeters, M. Rethore, and J. Lejeune, In vivo folic acid supplementation partially corrects in vitro methotrexate toxicity in patients with Down syndrome, British Journal of Haematology, vol.95, issue.3, pp.678-680, 1995.
DOI : 10.1007/BF00444952

J. Lejeune, M. Peeters, M. Rethore, and M. De-blois, Homocysteine and the methotrexate toxicity in trisomy 21, Cancer Chemotherapy and Pharmacology, vol.148, issue.5, pp.331-332, 1991.
DOI : 10.1007/BF00685122

J. Lejeune, M. Rethore, M. De-blois, and M. Peeters, Infantile psychosis, pseudo-Alzheimer syndrome, and trisomy 21. A trial of treatment with folinic acid: preliminary report, Therapie, vol.44, pp.115-121, 1989.

J. Lejeune, Pathogenesis of mental deficiency in trisomy 21, American Journal of Medical Genetics, vol.17, issue.Suppl 1, pp.20-30, 1990.
DOI : 10.1002/ajmg.1320370705

F. Bennett, S. Mcclelland, E. Kriegsmann, L. Andrus, and C. Sells, Vitamin and mineral supplementation in Down's syndrome, Pediatrics, vol.72, pp.707-713, 1983.

R. Bidder, P. Gray, R. Newcombe, B. Evans, and M. Hughes, THE EFFECTSOF MULTIVITAMINS AND MINERALS ON CHILDREN WITH DOWN SYNDROME, Developmental Medicine & Child Neurology, vol.4, issue.4, pp.532-537, 1989.
DOI : 10.1111/j.1469-8749.1989.tb04032.x

G. Smith, D. Spiker, C. Peterson, D. Cicchetti, and J. P. , Use of megadoses of vitamins with minerals in Down syndrome, The Journal of Pediatrics, vol.105, issue.2, pp.228-234, 1984.
DOI : 10.1016/S0022-3476(84)80118-3

R. Spector, Cerebrospinal fluid folate and the blood-brain barrier, Folic acid in neurology, psychiatry, and internal medicine, pp.187-194, 1979.

V. Prasher, Down Syndrome and Thyroid Disorders: A Review, Down Syndrome Research and Practice, vol.6, issue.1, pp.25-42, 1999.
DOI : 10.3104/reviews.95

P. Fort, F. Lifshitz, R. Bellisario, J. Davis, and R. Lanes, Abnormalities of thyroid function in infants with Down syndrome, The Journal of Pediatrics, vol.104, issue.4, pp.545-549, 1984.
DOI : 10.1016/S0022-3476(84)80544-2

D. Josse, Brunet-Lezine revise, echelle de developpement psychomoteur de la premiere enfance. Issy-Les-Moulineaux (France): Etablissements d'Applications Psychotechniques, 1997.

I. Lezine and O. Brunet, Presentation of a French scale of tests for infants, Ann Med Psychol, vol.108, p.499, 1950.

L. Francois and V. Des-portes, The main stages of psychomotor development from 0 to 3 years of age, Rev Prat, vol.54, pp.1991-1997, 2004.

S. Soldin, C. Brugnara, and J. Hicks, Pediatric reference ranges, 1999.

J. Coste, S. Bouee, E. Ecosse, A. Leplege, and J. Pouchot, Methodological issues in determining the dimensionality of composite health measures using principal component analysis: Case illustration and suggestions for practice, Quality of Life Research, vol.1, issue.3, pp.641-654, 2005.
DOI : 10.1007/s11136-004-1260-6

P. Brocker, P. Bonhomme, and J. Lods, Folates: de la deficience a la carence, La Revue de Geriatrie, vol.15, pp.365-373, 1990.

J. Ellis, H. Tan, R. Gilbert, D. Muller, and W. Henley, Supplementation with antioxidants and folinic acid for children with Down's syndrome: randomised controlled trial, BMJ, vol.336, issue.7644, pp.594-597, 2008.
DOI : 10.1136/bmj.39465.544028.AE

V. Fernandez, G. Tapia, P. Varela, P. Romanque, and D. Cartier-ugarte, Thyroid hormone-induced oxidative stress in rodents and humans: A comparative view and relation to redox regulation of gene expression, Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology, vol.142, issue.3-4, pp.231-239, 2006.
DOI : 10.1016/j.cbpc.2005.10.007

P. Venditti, D. Meo, and S. , Thyroid hormone-induced oxidative stress, Cellular and Molecular Life Sciences, vol.63, issue.4, pp.414-434, 2006.
DOI : 10.1007/s00018-005-5457-9

H. Erdamar, H. Demirci, H. Yaman, M. Erbil, and T. Yakar, The effect of hypothyroidism, hyperthyroidism, and their treatment on parameters of oxidative stress and antioxidant status, Clinical Chemistry and Laboratory Medicine, vol.46, issue.7, pp.1004-1010, 2008.
DOI : 10.1515/CCLM.2008.183

G. Santos, V. Afonso, G. Barra, M. Togashi, and P. Webb, Negative Regulation of Superoxide Dismutase-1 Promoter by Thyroid Hormone, Molecular Pharmacology, vol.70, issue.3, pp.793-800, 2006.
DOI : 10.1124/mol.106.025627

B. Catargi, F. Parrot-roulaud, C. Cochet, D. Ducassou, and P. Roger, Homocysteine, Hypothyroidism, and Effect of Thyroid Hormone Replacement, Thyroid, vol.9, issue.12, pp.1163-1166, 1999.
DOI : 10.1089/thy.1999.9.1163

B. Nedrebo, U. Ericsson, O. Nygard, H. Refsum, and P. Ueland, Plasma total homocysteine levels in hyperthyroid and hypothyroid patients, Metabolism, vol.47, issue.1, pp.89-93, 1998.
DOI : 10.1016/S0026-0495(98)90198-6

M. Diekman, N. Van-der-put, H. Blom, J. Tijssen, and W. Wiersinga, Determinants of changes in plasma homocysteine in hyperthyroidism and hypothyroidism, Clinical Endocrinology, vol.84, issue.2, pp.197-204, 2001.
DOI : 10.1056/NEJM199804093381507

W. Hussein, R. Green, D. Jacobsen, and C. Faiman, Normalization of Hyperhomocysteinemia with L-thyroxine in Hypothyroidism, Annals of Internal Medicine, vol.131, issue.5, pp.348-351, 1999.
DOI : 10.7326/0003-4819-131-5-199909070-00005

S. Hustad, B. Nedrebo, P. Ueland, J. Schneede, and S. Vollset, Phenotypic expression of the methylenetetrahydrofolate reductase 677C?.T polymorphism and flavin cofactor availability in thyroid dysfunction, Am J Clin Nutr, vol.80, pp.1050-1057, 2004.

J. Gueant, L. Xiaohong, S. Ortiou, P. Gerard, and S. Shue, The association between plasma homocysteine and holo-transcobalamin and the transcobalamin 776C?.G polymorphism is influenced by folate in the absence of supplementation and fortified diet, Am J Clin Nutr, vol.83, pp.171-172, 2006.

A. Ayav, J. Alberto, F. Barbe, L. Brunaud, and P. Gerard, Defective remethylation of homocysteine is related to decreased synthesis of coenzymes B2 in thyroidectomized rats, Amino Acids, vol.28, issue.1, pp.37-43, 2005.
DOI : 10.1007/s00726-004-0151-z

X. Chen, K. Jhee, and W. Kruger, S by Cystathionine ??-Synthase via the Condensation of Cysteine and Homocysteine, Journal of Biological Chemistry, vol.279, issue.50, pp.52082-52086, 2004.
DOI : 10.1074/jbc.C400481200